Oncobiologics, Inc. Series B Warrant
ONSIZ
ONSIZ was delisted on the 16th of May, 2018.
8 hedge funds and large institutions have $25K invested in Oncobiologics, Inc. Series B Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
20% less funds holding
Funds holding: 10 → 8 (-2)
58% less capital invested
Capital invested by funds: $60K → $25K (-$35K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3K |
| 3 |
VF
Virtu Financial
New York
|
-$1K |
| 4 |
Millennium Management
New York
|
-$133 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
ACA
2
Avoro Capital Advisors
New York
| $5K | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $4K | -$3K | -60,825 | -23% |
|
|
MWNA
4
Marshall Wace North America
New York
| $3K | – | – | – |
|
|
PC
5
PointState Capital
New York
| $2K | – | – | – |
|
|
6
Millennium Management
New York
| $1K | -$133 | -2,700 | -7% |
|
|
MIM
7
Monashee Investment Management
Boston,
Massachusetts
| $1K | – | – | – |
|
|
ACP
8
Acuta Capital Partners
Redwood City,
California
| – | -$5K | -96,833 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$1K | -11,980 | Closed |
|
ONSIZ Hedge Fund Activity: Q4 2017 in Review
8 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series B Warrant (ONSIZ) for Q4 2017, worth a combined $25K — down 58% from $60K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ONSIZ and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Acuta Capital Partners, exiting entirely with an estimated $5K sold.
- 8 institutional investors held Oncobiologics, Inc. Series B Warrant (ONSIZ) as of Q4 2017, down from 10 in Q3 2017.
- Funds reported $25K of Oncobiologics, Inc. Series B Warrant stock for Q4 2017, down 58% quarter-over-quarter.
- 0 funds opened new Oncobiologics, Inc. Series B Warrant positions in Q4 2017 and 2 closed out, a net change of -2 holders.
- The largest Oncobiologics, Inc. Series B Warrant seller in Q4 2017 was Acuta Capital Partners, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2017.